Open Access

Challenging paradigms and changing the course of chronic kidney disease (CKD) The era of SGLT2i

Event: ESC Asia with APSC & AFC 2020
Topic: Renal Failure and Cardiovascular Disease
Session type: Industry Technology and Innovation session
Sponsored by AstraZeneca
Date: 4 December 2020
Time: 17:00 - 17:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

2 presentations in this session

Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.

Speaker: Professor H. Heerspink (Groningen, NL)
Thumbnail

Q&A - Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.

Speaker: Professor H. Heerspink (Groningen, NL)
Speaker: Associate Professor J. Tan (Singapore, SG)
Thumbnail

3 speakers from this session

Professor Hiddo Heerspink

University Medical Centre Groningen, Groningen (Netherlands (The))
5 presentations
0 follower

Professor Hiddo Heerspink

University Medical Centre Groningen, Groningen (Netherlands (The))
5 presentations
0 follower

Associate Professor Jack Wei Chieh Tan

National Heart Centre Singapore, Singapore (Singapore)
16 presentations
2 followers

This platform is supported by

logo Novo Nordisk